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Abstract: Colorectal cancer (CRC) is the third-ranked neoplasm in order of incidence and 
mortality, worldwide, and the second cause of cancer death in industrialized countries. One of 
the most important environmental risk factors for CRC is a Western-type diet, which is char-
acterized by a low-fiber and high-fat content. Up to 25% of patients with CRC have a family 
history for CRC, and a fraction of these patients are affected by hereditary syndromes, such 
as familial adenomatous polyposis, Gardner or Turcot syndromes, or hereditary nonpolyposis 
colorectal cancer. The onset of CRC is triggered by a well-defined combination of genetic 
alterations, which form the bases of the adenoma-carcinoma sequence hypothesis and justify 
the set-up of CRC screening techniques. Several screening and diagnostic tests for CRC are 
illustrated, including rectosigmoidoscopy, optical colonoscopy (OC), double contrast barium 
enema (DCBE), and computed tomography colonography (CTC). The strengths and weaknesses 
of each technique are discussed. Particular attention is paid to CTC, which has evolved from 
an experimental technique to an accurate and mature diagnostic approach, and gained wide 
acceptance and clinical validation for CRC screening. This success of CTC is due mainly to its 
ability to provide cross-sectional analytical images of the entire colon and secondarily detect 
extracolonic findings, with minimal invasiveness and lower cost than OC, and with greater detail 
and diagnostic accuracy than DCBE. Moreover, especially with the advent and widespread avail-
ability of modern multidetector CT scanners, excellent quality 2D and 3D reconstructions of 
the large bowel can be obtained routinely with a relatively low radiation dose. Computer-aided 
detection systems have also been developed to assist radiologists in reading CTC examinations, 
improving overall diagnostic accuracy and potentially speeding up the clinical workflow of 
CTC image interpretation.
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computed tomography colonography
Colorectal cancer: epidemiology and risk factors
Colorectal cancer (CRC) is the third-ranked neoplasm in order of incidence and 
mortality worldwide.1 It is more frequent in industrialized countries, where it is 
the second cause of cancer death and is a social and health care issue of major 
importance.1,2
In 2009, 146,970 new cases of CRC and 49,920 CRC-related deaths occurred in 
the United States.3,4 In the European Union, approximately 220,000 new CRC cases 
per year are estimated to be diagnosed annually.5
The likelihood of developing CRC increases from the second to the ninth decade. 
CRC is rare before the age of 40 years, and most cases are diagnosed after the age of 50. 
The incidence of CRC is slightly higher in males than in females, especially for rectal Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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carcinoma. In developing countries CRC has a lower, yet 
growing incidence.1 Although the etiology of CRC is still 
unknown, epidemiological and biomolecular studies have 
unveiled environmental and genetic risk factors that favor 
the onset of CRC.3
One of the most important environmental risk factors for 
CRC is a Western-type diet, which is characterized by a low 
fiber and high fat content. CRC-related mortality is directly 
correlated with per-person calorie intake, high consumption 
of meat proteins and fat, and high blood cholesterol levels. 
Conversely, in African populations, in which consumption 
of fruit and vegetables is higher than in Western countries, 
the incidence of CRC is much lower. Moreover, it has been 
observed that people who have migrated to industrialized 
countries tend to acquire the same CRC incidence rates of 
those countries, supporting the hypothesis that geographic 
differences in CRC incidence are due to dietary habits rather 
than different genetic patterns.6
Research has shown that up to 25% of patients with CRC 
have inherited mutations that increase their risk for CRC. 
A fraction of these patients are affected by well-characterized 
hereditary syndromes, which can be classified as polyposis 
and nonpolyposis CRC:
•	 Familial adenomatous polyposis (FAP; also known 
as familiar polyposis of the colon) is a rare autosomal 
dominant condition that causes the growth of hundreds 
or thousands of adenomatous polyps in the large bowel. 
It is associated with a deletion in the long arm of 
chromosome 5, which contains the APC oncosuppressor 
gene. CRC develops in almost all affected patients under 
40 years. There is a classic form (in which patients typi-
cally harbor between 500 and 2500 colonic adenomas) 
and an attenuated form of FAP, characterized by a lower 
number of polyps (typically 30) that are predominantly 
located in the proximal colon. Affected patients may also 
have associated extracolonic diseases, such as desmoid 
tumors and gastroduodenal carcinomas.7
•	 Gardner syndrome is characterized by a combination 
of intestinal polyposis (identical to classic FAP) and 
numerous osteomas, epidermal cysts, fibromatosis, as 
well as thyroid and duodenal carcinomas and dental 
abnormalities.
•	 Turcot syndrome is a rare condition characterized by the 
association of FAP and tumors of the central nervous 
system (such as medulloblastoma and glyoblastoma).3
•	 Hereditary nonpolyposis colorectal cancer (HNPCC, also 
known as Lynch syndrome) is an autosomal dominant 
hereditary syndrome, associated with germline mutations 
in genes that result from DNA repair mechanisms 
(in particular, MSH2, MLH1, PMS, and PMS2), causing 
microsatellite DNA instability and impaired mismatch 
repair, and leading to higher risk of cancer development. 
A strong association exists between HNPCC and endo-
metrial and ovarian carcinomas.8 In HNPCC patients, 
CRC typically occurs earlier than 50 years, that is, 10 to 
15 years before the average onset of CRC in the overall 
population. Moreover, CRC in HNPCC patients is more 
frequently located in the cecum or ascending colon.3,9
•	 Chronic inflammatory bowel diseases: CRC is more 
frequent in patients with ulcerative colitis, in whom the 
absolute risk of cancer increases at a rate of 0.5% to 1% 
per year after 10 years of disease, with cancer development 
typically in 8% to 30% of cases after 25 years from disease 
onset. Conversely, in patients with Crohn disease, CRC risk 
is not significantly higher than in the normal population.3
Other conditions that increase the risk for CRC develop-
ment are:
•	 Bacteremia related to Streptococcus bovis: for unknown 
reasons, individuals with a history of S. bovis-induced 
endocarditis or sepsis have a higher incidence of CRC.3
•	 Tobacco smoke, which is associated with the develop-
ment of colorectal adenomas: several studies have inves-
tigated the potential procarcinogenetic role of tobacco 
smoke, and a dose–response relationship with CRC has 
been found for cigarette pack-years, smoking duration, 
smoking intensity, smoking history in the distant past, 
and younger age at initiation of smoking.10,11
•	 Alcohol abuse: epidemiological studies have demonstrated 
that another risk for CRC could arise from the malnutrition 
caused by lower folate concentrations in heavy alcohol 
drinkers. However, recent studies have yielded inconsis-
tent findings concerning such a relationship.12–14
Despite multiple risk factors increasing the likelihood of 
CRC development, the majority of individuals (about 75%) 
who develop CRC do not have specific risk factors.15 
Therefore, the population should be stratified into average-
risk individuals (age greater than 50 years, no personal risk 
factors, no familial history of CRC) and those with moderate 
(first-degree relative with a history of adenoma or carcinoma, 
or personal history of large adenoma or carcinoma) and high 
CRC risk (inflammatory bowel disease or a family history 
of an inherited CRC syndrome).16,17
The adenoma-carcinoma sequence
The onset of CRC is triggered by a well-defined sequence 
of genetic alterations that form the etiological basis of the Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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adenoma-carcinoma sequence hypothesis and justify the 
rationale for CRC screening. The validity of this hypothesis 
is supported by several findings:18
•	 Populations with a high incidence of adenomas have a 
high prevalence of CRC, and vice versa.
•	 There is a substantial overlap between the topographic 
distribution of colorectal adenomas and that of CRC.
•	 The incidence peak of adenomatous polyps precedes that 
of CRC by some years.
•	 The risk of CRC is directly proportional to the number 
of adenomas, and the substantial certainty of develop-
ing CRC in patients with FAP is an extreme case of this 
rule.
•	 Follow-up programs to detect adenomas with resection of 
suspected lesions are associated with a reduced incidence 
of CRC.
Polyps with the highest risk of neoplastic degeneration 
are those characterized by a large size ($20 mm), villous 
histology, and sessile morphology. The time of progression 
from adenomatous polyp to carcinoma is about 10 years.
More than 90% of CRCs arise from adenomatous polyps,19 
while a small fraction of CRCs develop without evidence of 
an adenomatous precursor, suggesting that some lesions 
may undergo malignant transformation without passing 
through a polypoid intermediate phase. Evidence exists that 
polypectomy can reduce CRC incidence and mortality by 
interrupting the adenoma-carcinoma sequence in the colonic 
segment where the polyp has been excised.20
From a genetic point of view, carcinogenesis is character-
ized by the accumulation of multiple, consecutive mutations in 
oncogenes and oncosuppressor genes, starting the adenoma-
carcinoma sequence at the level of the colonic mucosa. The 
genes most often involved (and the most widely known) are 
APC, k-RAS, p53, SMAD2, and SMAD4. Moreover, mutations 
involved in DNA mismatch repair may account for the devel-
opment of 10% to 15% of sporadic CRC and HNPCC.18
CRC screening
The knowledge of the biological mechanisms underlying 
CRC carcinogenesis and their slow progression over time 
make this neoplasm ideal for the development of screening 
programs. Furthermore, CRC is a common disease with a 
high mortality rate, for which risk conditions can be detected 
and treatment is more effective in early than in advanced 
disease stages.
To be effective, screening needs to be performed on 
a large population, and be sensitive, specific, and well 
tolerated by patients. Furthermore, it is essential that effective 
treatment is available once diagnosis has been made. Finally, 
screening must be cost-effective.
Based on the guidelines of the American Cancer Society, 
techniques currently available for the secondary preven-
tion of CRC (after the age of 50 years) can be classified as 
follows:21
Tests for detecting polyps and CRC:
Flexible rectosigmoidoscopy (every 5 years);
Optical colonoscopy (OC, every 10 years);
Double contrast barium enema (DCBE, every 5 years);
  Computerized tomography colonography (CTC, also 
known as virtual colonoscopy: every 5 years).
Tests that can make CRC diagnosis:
Fecal occult blood test (FOBT, every year);
Fecal immunochemical tests (every year);
Fecal DNA test (uncertain time interval).
It must be pointed out that individuals with an increased/
high CRC risk should undergo screening with a higher 
frequency based on their individual risk level. In Western 
countries, the most common and readily available tests for 
CRC screening are rectosigmoidoscopy, OC, and FOBT. 
Since the introduction of FOBT as a CRC screening test in 
the 1990s, CRC mortality has been reduced; however, the 
main limitations of FOBT are a low specificity and a low 
sensitivity in polyp detection (about 10%), as polyps seldom 
manifest with bleeding, although, for this same reason, 
immunochemical FOBT has a sensitivity and specificity of 
95% for detection of advanced colonic neoplasms.22
Therefore, it is necessary to shift attention earlier along 
the adenoma-carcinoma sequence: this task is accomplished 
by rectosigmoidoscopy and colonoscopy (either optical or 
virtual).
The rationale for rectosigmoidoscopy (also referred to as 
left colonoscopy if exploration is extended to the descending 
colon) is related to different frequency of CRC in the various 
colonic segments; in fact, CRC arises in the rectum and 
sigmoid colon in 55% of cases, in the descending colon in 
6% of cases, in the transverse colon in 11% of cases, and in 
the cecum/ascending colon in 22% of cases.18 One limita-
tion of this technique is, of course, the lack of evaluation 
of the entire colorectum, that may cause a considerable 
number of colonic adenomas and carcinomas to be missed. 
In recent years proximal colon CRC has been reported more 
frequently, especially in elderly individuals and females. 
For those reasons, whenever a colonic mass, or an advanced 
adenoma, or 3 or more adenomas, or a villous polyp larger 
than 10 mm is found, rectosigmoidoscopy must be followed 
by complete colonoscopy.17Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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OC is today regarded as the gold standard technique for 
CRC screening, because it allows lesion detection with both 
high sensitivity (90%–100% also for small size polyps, ie, less 
than 6 mm diameter) and high specificity. Moreover, like recto-
sigmoidoscopy, OC is not only useful for diagnostic purposes, 
but has also a therapeutic role as it enables polypectomy by 
means of a diathermic loop or hot bioptic pliers (hot biopsy), 
allowing lesion removal and biopsy. It is usually performed 
with light sedation or conscious sedation and therefore requires 
an in-patient setting. However, the main limitation of OC is 
patient intolerance, which can be due either to anatomical 
conditions (for example, presence of short colonic mesentery 
or a redundant colon may cause pain with progression of the 
OC probe), adhesions, or neoplastic and/or fibrotic narrowing/
obstruction of the bowel lumen. Other limitations of OC are 
the need for a cathartic preparation for optimal bowel cleans-
ing, its high cost, and invasiveness. Moreover, some lesions 
of the colonic mucosa can be missed even by OC.23 Finally, 
OC is not completely free from potentially life-threatening 
complications, such as bowel perforation or bleeding.
DCBE is often used whenever conventional endoscopy 
fails to explore the entire colon, eg, because of patient 
intolerance and/or inability to reach the cecum on OC 
(which is not uncommon in cases of redundant bowel) 
(Figure 1). Compared with OC, DCBE has the advantage of 
less invasiveness, and therefore it is usually better tolerated 
by patients. However, the visualization of colonic lesions 
is heavily dependent on the radiographic projections made 
to obtain DCBE images, and therefore polyps (especially 
smaller ones) could be masked by extracolonic structures 
or even by nearby colonic segments or folds, thus causing 
DCBE to be less sensitive than OC. Sensitivities as low as 
42% for 10 mm polyps have been reported.24,25
Another important issue of DCBE is radiation dose, that 
can be quite unpredictable due to the different radiographic 
technique used for each patient (for example, particular 
anatomic conditions and/or the different time and maneuvers 
needed to ensure arrival of barium and air up to the cecum), 
but it tends to be quite high, in the order of 5 to 8 mSv. Larger 
patients usually require even higher radiation doses to be 
imaged, owing to their higher X-ray absorption. This may be 
a serious limitation in case of younger patients and especially 
for young females, who are more sensitive to ionizing radia-
tion due to the presence of gonads inside the abdomen.
CTC has recently been included by the American Cancer 
Society among tests recommended for CRC screening, and 
has evolved from an experimental technique to a universally 
recognized, accurate, and validated diagnostic tool that is 
gaining widespread use and acceptance among both patients 
and referring clinicians. It is based on the acquisition of spiral 
CT data of the abdomen after adequate distention of the 
colon through rectal insufflation of gas (either air or carbon 
dioxide).26–28 The CT acquisition is usually performed twice: 
once in the supine position and then in the prone position (or 
vice versa): this is to optimize distention of the various colonic 
segments depending on gravitational compression by the sur-
rounding abdominal structures, as well as to distinguish polyps 
(that are fixed to the bowel walls) from fluid and/or fecal resi-
dues (that tend to fall down due to gravitation) (Figure 2).
As CTC image formation is based on the X-ray attenuation 
of low-density, high-intrinsic-contrast objects (such as the air 
contained in the colonic lumen vs the large bowel walls, acting 
Figure 1 Large carcinoma of the cecum (red circle) as displayed on double contrast 
barium enema image. Lesion presence is inferred indirectly as a filling defect of the 
cecal lumen with irregular mucosal lining.
Figure 2 Computed tomography colonography image in the supine a) and prone 
b) position. in the supine position the collapsed sigmoid colon may mimic cancer, 
while on the prone position the bowel walls and the lumen are shown to be normal 
(red arrows).Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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as an interface between intraluminal air and the extraluminal 
compartment), low X-ray energy is sufficient to achieve diag-
nostic CTC images, resulting in a low radiation dose. In other 
terms, if CTC is aimed at the sole examination of the colon 
(eg, for CRC screening purposes), use of low-radiation-dose 
CT acquisition protocols is warranted. Conversely, regular-
dose CT protocols will be used if CTC is part of a CT exami-
nation in which all abdominal organs are to be investigated. 
This is the case, for example, of CTC in patients with known 
CRC and incomplete OC, in whom CT plays a role both for 
complete assessment of the colonic lumen and for oncological 
staging (including search of lymph node and liver metastases, 
or peritoneal carcinomatosis) (Figure 3).
For adequate colonic distention to be achieved, air or 
carbon dioxide is usually delivered into the patient’s colon by 
means of a thin rectal catheter prior to CTC data acquisition. 
Insufflation can be accomplished either manually or via 
automatic insufflators, which allow a continuous and reliable 
measurement of the volume and pressure of insufflated gas. Air 
has the advantage of no cost and ease of administration, but is 
less tolerated because it is not absorbed by the colonic mucosa. 
Conversely, carbon dioxide is more comfortable (after comple-
tion of the exam) as it is gradually absorbed by the colonic 
walls, although larger volumes must be supplied compared 
with air. In practical terms, administration of 1 to 1.5 L of air 
or 3 to 4 L of carbon dioxide is usually sufficient.28
Colonic distention is also favored by parenteral adminis-
tration of spasmolytic agents, such as glucagon or hyoscine-N-
butyl bromide, which inhibit peristalsis and reduce the tone of 
the parietal musculature. Such agents are usually administered 
intramuscularly or intravenously prior to insufflation. 
  Contraindications to hyoscine-N-butyl bromide are glaucoma, 
prostatic hypertrophy, and heart rhythm disorders, whereas 
glucagon is contraindicated in patients with elevated blood 
glucose levels. In the United States (where glucagon is the 
only option) most experts have stopped using it.
By orally administering positive contrast material into 
the large bowel (barium or iodine), fecal and fluid tagging 
can be performed, helping to distinguish fecal/fluid residues 
from parietal polyps. Tagged residual fluid can then be elec-
tronically removed from CTC images by means of dedicated 
software. Research is in progress on subtracting solid tagged 
stool in patients who undergo no cathartic cleansing.
In contrast with the 2D plain film nature of DCBE images, 
one great advantage of CTC is the fact that cross-sectional 
images of the abdomen are acquired, which allows analysis 
of the various anatomical structures (eg, colonic lumen and 
content vs bowel walls, and the several components of the 
extracolonic compartment) without the superimposition of 
the surrounding organs and tissues. CTC also allows quan-
titative measurements of CT densities (such as that of fat 
for the normal ileo-cecal valve, or parenchymal density for 
extracolonic tissues or colonic lesions), as well as quantita-
tive geometrical information, such as distances, areas, or 
volumes, without the projective distortion that is typical of 
radiographic images.
In order to achieve a high spatial resolution (which is 
essential for detection of small polyps and for high quality 2D 
and 3D image processing), thin slice acquisition is mandatory 
for CTC examinations. With current multidetector row CT 
equipment (64 detector rows and beyond), the entire abdomen 
can be scanned in less than 10 seconds with submillimeter 
slice thickness, resulting in voxel isotropy and elimination/
minimization of motion artifacts.29
2D and 3D image reconstructions are necessary 
components of any CTC exam, as they allow assessment of 
large bowel anatomy on multiple planes (either orthogonal 
[axial, coronal, and sagittal planes], or user-defined oblique 
planes), as well as provision of a volumetric depiction of 
normal anatomy and polyp morphology. 3D reconstructions 
enable accurate quantification of polyp volume, which can 
be helpful in a follow-up to assess growth of the polyp. With 
modern multidetector CT equipment and powerful image 
processing workstations, 2D (multiplanar reformation) and 
3D reconstructions (volume rendering) are now part of the 
routine diagnostic workflow of CTC. It is also possible to 
perform volume rendering from an intraluminal perspective, 
thus simulating endoscopic navigation (virtual endoscopy), or 
Figure 3 a) Annular stenosing cancer of the right colonic flexure (red circle) using 
a low dose computed tomography colonography (CTC) protocol. b, c) CTC can be 
performed with a regular dose protocol for detection of extracolonic disease, such 
as lung (b: white circle) and liver metastases (c: red arrows) in a patient with locally 
advanced colorectal cancer (red asterisk).Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
22
Neri et al
to ‘open up’ the colon and generate dissected views (virtual 
dissection) (Figures 4 and 5).
In the systematic review by Halligan et al in 2005,30 who 
assessed 24 studies for a total of 4181 patients, average CTC 
sensitivity for large polyp (1 cm or above) detection was 93% 
with an average specificity of 97%. For large and medium 
size polyps (6 mm or above), average sensitivity and speci-
ficity were both 86%, while for polyps of all sizes, sensitivity 
ranged from 45% to 97% and specificity from 26% to 97%. 
CTC sensitivity for detection of CRC was 96%.30
In another systematic review of the literature by 
Mulhall et al,31 results were substantially similar to those 
by Halligan et al.30 In summary, CTC has been shown to be 
highly sensitive for CRC detection, as well as highly specific 
for detection of small size polyps, which makes it suitable as 
a CRC screening tool.32,33
CTC vs DCBE: radiation dose issues
Few studies have compared the radiation dose of CTC 
and DCBE.34,35 Hirofuji et al34 measured a DCBE effective 
dose value of 12.7 mSv (decreasing by 12% when digital 
radiography equipment was used), while an effective dose 
of CTC performed with a low-dose protocol was 5.7 mSv. 
Neri et al managed to perform successful CTC examina-
tions for CRC screening purposes with an even lower 
radiation dose (2.2 mSv) by using a combination of low 
exposure settings and tube current modulation.36 The lower 
radiation dose of CTC compared with DCBE is due to the 
fact that with CTC, fluoroscopy is not needed and data 
acquisition is performed in the supine and prone positions 
only. Single-acquisition protocols are currently discussed 
(eg, in the pediatric population), which would actually halve 
radiation exposure.37
According to the radiological risk figures of the Interna-
tional Commission on Radiological Protection,38 an average 
effective dose value of around 2 mSv for CTC is associated 
with a theoretical 0.005% risk of lethal radiation-induced 
malignancy, which further decreases with increasing 
patient age. Thus, CTC is an important CRC screening tool 
especially in middle-aged and elderly patients, in whom the 
potential benefit of early diagnosis of CRC far outweighs 
the risk associated with radiation exposure.
Computer aided diagnosis
Computer aided diagnosis (CAD) tools are software applica-
tions designed for assisting the radiologist in the diagnosis 
of several conditions; for detection of lung nodules on chest 
X-ray or CT, breast nodules in screening mammography, 
and polyps in CT colonography.39–41
As CTC continues to evolve and improve, its use is 
shifting from highly specialized academic centers to com-
munity hospitals and nonacademic radiology practices.42,43 
Thus, many radiologists are experiencing pressure from clini-
cal colleagues to offer CTC as part of the routine services 
provided in their practices.
In parallel, modern multidetector CT scanners can 
generate data with unprecedented spatial resolution (down 
to 0.5 mm), with a consequent enormous increase in image 
number; therefore, manual reading of CTC images may 
become error-prone due to reader fatigue.44 Moreover, image 
interpretation is subject to reader bias, and no systematic 
method has been devised so far for lesion visualization 
(either 2D or 3D).45
CAD systems have been developed in an attempt to 
overcome the limitations of software-unassisted reading of 
Figure 4 Sessile polyp of the ascending colon: a) native axial image (red arrow), 
b) virtual endoscopic view (red asterisk).
Figure  5  Pedunculated  polyp  of  the  ascending  colon:  a)  native  axial  image, 
b) coronal reformation, c) sagittal reformation (red arrows), d) virtual endoscopic 
view (white asterisk).Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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CTC datasets. Such applications include dedicated algorithms 
for automatic detection of geometrical properties of image 
objects (such as the shape of colonic polyps and their relation-
ship with the bowel wall) and CT density of the normal colon 
and polyps. The output of those algorithms is used to create 
a list of ‘candidate’ polyps, which are shown on 2D and 3D 
reconstructions and native CTC images, and which must be 
validated or rejected by the user. CAD systems can be used 
in a first-reader or second-reader paradigm, depending on 
CAD being switched on before or after examination of CTC 
datasets by the human reader. Several studies have addressed 
the issue of evaluating the diagnostic performance of CAD 
systems for CTC. They are valuable for assisting radiologists 
in the detection of polyps, especially for detection of small 
lesions. However, such an increase in sensitivity is usually 
paralleled by a decrease of specificity, suggesting that results 
of CAD systems need to be adjusted to maximize overall 
diagnostic accuracy.39–41
The impact of CAD as second reader on experienced 
readers has recently been investigated in a multireader, 
multicase trial.46 Thus, it would be of interest to evaluate 
the impact of CAD systems on the diagnostic performance 
of readers without dedicated CTC experience, such as 
readers working in nonacademic centers, involved in 
reading a large amount of CTC generated by a screening 
program. In this respect, Baker et al47 have concluded that 
application of a CAD system for CTC is advantageous for 
assisting diagnostic performance of inexperienced readers, 
with decreased specificity being offset by a higher increase 
in sensitivity. However, CAD power cannot compensate 
for reader inexperience, as it has been shown that use of 
CAD software for CTC image evaluation by inexperienced 
readers does not significantly increase sensitivity of indi-
vidual raters, thus stressing the importance of adequate 
training.48
Conclusion
Colorectal cancer is one of the most frequent malignancies in 
the Western world, for which genetic and environmental risk 
factors have been identified and form the basis for disease 
prevention. Several imaging techniques are currently avail-
able that allow detection of colorectal polyps at an early stage 
of development. Among those, CT colonography is one of the 
most promising and will likely gain increasing importance 
for CRC screening purposes.
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